Covestor’s Vir Biotechnology VIR Stock Holding History

Covestor’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	11	–	–	﹤0.01%	2812
2025 Q4	$0	Hold	11	–	–	﹤0.01%	2777
2025 Q3	$0	Hold	11	–	–	﹤0.01%	2818
2025 Q2	$0	Sell	11 -1	-8%	-$5	﹤0.01%	2798
2025 Q1	$0	Sell	12 -15	-56%	-$133	﹤0.01%	2768
2024 Q4	$0	Buy	27 +16	+145%	+$126	﹤0.01%	2784
2024 Q3	$0	Sell	11 -1	-8%	-$9	﹤0.01%	2815
2024 Q2	$0	Hold	12	–	–	﹤0.01%	2801
2024 Q1	$0	Sell	12 -1	-8%	-$10	﹤0.01%	2788
2023 Q4	$0	Sell	13 -4,524	-100%	-$41.3K	﹤0.01%	2764
2023 Q3	$43K	Sell	4,537 -4,668	-51%	-$66.6K	0.03%	834
2023 Q2	$226K	Buy	9,205 +9,196	+102,178%	+$231K	0.17%	86
2023 Q1	$0	Hold	9	–	–	﹤0.01%	2631
2022 Q4	$0	Hold	9	–	–	﹤0.01%	2650
2022 Q3	$0	Sell	9 -190	-95%	-$4.83K	﹤0.01%	2662
2022 Q2	$5K	Sell	199 -83	-29%	-$1.94K	﹤0.01%	1434
2022 Q1	$7K	Buy	282 +125	+80%	+$3.71K	﹤0.01%	1430
2021 Q4	$7K	Buy	+157	New	+$6.15K	0.01%	1182

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return